A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)

Clinical trial NCT01054443 · TERMINATED

Trial details

NCT number: NCT01054443
Sponsor: Shionogi
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia (ITP)

Start date: 2010-03-18
Primary completion: 2010-11-24
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.